Swedbank AB Makes New Investment in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Swedbank AB acquired a new stake in Sabra Healthcare REIT, buying 1,106,800 shares valued at approximately $19.3 million, which represents about 0.47% of the company.
• Sabra Healthcare REIT reported quarterly earnings of $0.38 EPS, exceeding estimates and showing a 7.4% increase in revenue compared to the previous year.
• A quarterly dividend of $0.30 per share was declared, reflecting a dividend yield of 6.3%, with a payout ratio of 157.89%.

Swedbank AB purchased a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,106,800 shares of the real estate investment trust's stock, valued at approximately $19,336,000. Swedbank AB owned 0.47% of Sabra Healthcare REIT at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Allspring Global Investments Holdings LLC bought a new position in shares of Sabra Healthcare REIT during the first quarter worth about $298,000. New York State Teachers Retirement System boosted its stake in shares of Sabra Healthcare REIT by 12.1% during the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock worth $5,619,000 after acquiring an additional 34,591 shares during the period. M&T Bank Corp boosted its stake in shares of Sabra Healthcare REIT by 2.1% during the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock worth $905,000 after acquiring an additional 1,059 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in Sabra Healthcare REIT by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock valued at $331,000 after purchasing an additional 853 shares during the period. Finally, Ethos Financial Group LLC bought a new stake in Sabra Healthcare REIT in the 1st quarter valued at $1,150,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Down 0.8%

Shares of SBRA traded down $0.15 during mid-day trading on Friday, reaching $18.71. The company had a trading volume of 3,923,838 shares, compared to its average volume of 2,041,152. The company has a market capitalization of $4.49 billion, a price-to-earnings ratio of 24.62, a price-to-earnings-growth ratio of 1.50 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The firm has a 50-day moving average price of $18.73 and a 200 day moving average price of $18.05.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company's revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.4%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.

Analyst Ratings Changes

Several analysts recently issued reports on SBRA shares. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Truist Financial upped their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research report on Tuesday, September 2nd. BMO Capital Markets upped their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. JMP Securities increased their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Finally, Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $20.83.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.